CoChat

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles

Open access
Xiong, Xunhao, Arvizo, Rochelle R., Saha, Sounik, Robertson, David J., McMeekin, Scott, Bhattacharya, Resham, Mukherjee, Priyabrata · 2014 · Oncotarget
Cited by 73

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

// Xunhao Xiong 1,* , Rochelle R. Arvizo 2,* , Sounik Saha 1 , David J. Robertson 3 , Scott McMeekin 4,5 , Resham Bhattacharya 4,5 and Priyabrata Mukherjee 5 1 Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 2 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, MN 3 Department of Chemistry and University of Missouri Research Reactor, University of Missouri, Columbia, Missouri 4 Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 5 Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma * These authors contributed equally to this work Correspondence: Priyabrata Mukherjee, email: // Keywords : gold nanoparticle; chemoresistance; cancer stem cell; EMT; NF-kappa B Received : May 22, 2014 Accepted : July 11, 2014 Published : July 11, 2014 Abstract Recently we reported that gold nanoparticles (AuNPs) inhibit ovarian tumor growth and metastasis in mice by reversing epithelial-mesenchymal transition (EMT). Since EMT is known to confer drug resistance to cancer cells, we wanted to investigate whether anti-EMT property of AuNP could be utilized to sensitize ovarian cancer cells to cisplatin. Herein, we report that AuNPs prevent cisplatin-induced acquired chemoresistance and stemness in ovarian cancer cells and sensitize them to cisplatin. AuNPs inhibit cisplatin induced EMT, decrease the side population cells and key stem cell markers such as ALDH1, CD44, CD133, Sox2, MDR1 and ABCG2 in ovarian cancer cells. Mechanistically, AuNPs prevent cisplatin-induced activation of Akt and NF-kB signaling axis in ovarian cancer cells that are critical for EMT, stem cell maintenance and drug resistance. In vivo , AuNPs sensitize orthotopically implanted ovarian tumor to a low dose of cisplatin and significantly inhibit tumor growth via facilitated delivery of both AuNP and cisplatin. These findings suggest that by depleting stem cell pools and inhibiting key molecular pathways gold nanoparticles sensitize ovarian cancer cells to cisplatin and may be used in combination to inhibit tumor growth and metastasis in ovarian cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2203

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 73

Metadata

Authors
Xiong, X., Arvizo, R. R., Saha, S., Robertson, D. J., McMeekin, S., Bhattacharya, R., & Mukherjee, P.
Venue
Oncotarget
Published
2014-07-11
Volume
5
Issue
15
Pages
6453-6465
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1525515409
Cited by
73
References
6
FWCI
2.73
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. https://app.cochat.ai/papers/10.18632/oncotarget.2203
The paper
Xiong, X., Arvizo, R. R., Saha, S., Robertson, D. J., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2014). Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. Oncotarget. https://doi.org/10.18632/oncotarget.2203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.